Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cutts

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Science Translational Medicine|November 13, 2015
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancerGaia Schiavon, Sarah Hrebien, Isaac Garcia-Murillas, et al.
Cancer Discovery|November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast CancerBelinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
Cancer Research|March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast CancerMaria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH TrialIseult M Browne, Javier Pascual, Rosalind J Cutts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Whole genome sequencing-powered ctDNA sequencing for breast cancer detectionI Garcia-Murillas, C W Abbott, R J Cutts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast CancerMaria Coakley, Guillermo Villacampa, Prithika Sritharan, et al.
JAMA Oncology|August 2, 2019
Assessment of Molecular Relapse Detection in Early-Stage Breast CancerIsaac Garcia-Murillas, Neha Chopra, Iñaki Comino-Méndez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programmeMichael Davidson, Lauren I Aronson, Julie Howard-Reeves, et al.
Breast Cancer Research and Treatment|October 18, 2024
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancerIsaac Garcia-Murillas, Rosalind J Cutts, Giselle Walsh-Crestani, et al.
Nature Communications|April 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Science Translational Medicine|November 13, 2015
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancerGaia Schiavon, Sarah Hrebien, Isaac Garcia-Murillas, et al.
Cancer Discovery|November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast CancerBelinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
Cancer Research|March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast CancerMaria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH TrialIseult M Browne, Javier Pascual, Rosalind J Cutts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Whole genome sequencing-powered ctDNA sequencing for breast cancer detectionI Garcia-Murillas, C W Abbott, R J Cutts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast CancerMaria Coakley, Guillermo Villacampa, Prithika Sritharan, et al.
JAMA Oncology|August 2, 2019
Assessment of Molecular Relapse Detection in Early-Stage Breast CancerIsaac Garcia-Murillas, Neha Chopra, Iñaki Comino-Méndez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programmeMichael Davidson, Lauren I Aronson, Julie Howard-Reeves, et al.
Breast Cancer Research and Treatment|October 18, 2024
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancerIsaac Garcia-Murillas, Rosalind J Cutts, Giselle Walsh-Crestani, et al.
Nature Communications|April 24, 2021
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Pageof 5